These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5641123)

  • 21. Genotoxicity of a variety of pyrrolizidine alkaloids in the hepatocyte primary culture-DNA repair test using rat, mouse, and hamster hepatocytes.
    Mori H; Sugie S; Yoshimi N; Asada Y; Furuya T; Williams GM
    Cancer Res; 1985 Jul; 45(7):3125-9. PubMed ID: 4005849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated intakes of pyrrolizidine alkaloids by humans. A comparison with dose rates causing tumors in rats.
    Culvenor CC
    J Toxicol Environ Health; 1983; 11(4-6):625-35. PubMed ID: 6620404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malformations in foetal rats induced by the pyrrolizidine alkaloid, heliotrine.
    GREEN CR; CHRISTIE GS
    Br J Exp Pathol; 1961 Aug; 42(4):369-78. PubMed ID: 13708161
    [No Abstract]   [Full Text] [Related]  

  • 24. Disturbance of voltage-induced cellular calcium entry by marine dimeric and tetrameric pyrrole--imidazole alkaloids.
    Bickmeyer U; Grube A; Klings KW; Köck M
    Toxicon; 2007 Sep; 50(4):490-7. PubMed ID: 17570456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advance on pharmacologic actions, toxicity and pharmacokinetics of pyrrolizidine alkaloids].
    Gao J; Wang C; Li Y; Wang Z
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):506-11. PubMed ID: 19526771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicoproteomic assessment of liver responses to acute pyrrolizidine alkaloid intoxication in rats.
    Li YH; Tai WC; Khan I; Lu C; Lu Y; Wong WY; Chan WY; Wendy Hsiao WL; Lin G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018 Apr; 36(2):65-83. PubMed ID: 29667502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and secondary pyrrolic metabolites of pyrrolizidine alkaloids form DNA adducts in human A549 cells.
    He X; Xia Q; Wu Q; Tolleson WH; Lin G; Fu PP
    Toxicol In Vitro; 2019 Feb; 54():286-294. PubMed ID: 30366057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation into the carcinogenicity of monocrotaline pyrrole.
    Hooson J; Grasso P; Mattocks AR
    J Pathol; 1973 Jul; 110(3):P8-9. PubMed ID: 4744071
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editor's Highlight: Identification of Any Structure-Specific Hepatotoxic Potential of Different Pyrrolizidine Alkaloids Using Random Forests and Artificial Neural Networks.
    Schöning V; Hammann F; Peinl M; Drewe J
    Toxicol Sci; 2017 Dec; 160(2):361-370. PubMed ID: 28973379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.
    Gao H; Ruan JQ; Chen J; Li N; Ke CQ; Ye Y; Lin G; Wang JY
    Drug Des Devel Ther; 2015; 9():4861-8. PubMed ID: 26346783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of acute toxicity of Ukrain in rats after intravenous injection.
    Kulik GI; Deneka ER; Todor IN; Karmozina LG
    Drugs Exp Clin Res; 1998; 24(5-6):287-93. PubMed ID: 10190089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental pulmonary hypertension (author's transl)].
    Kuriyama T; Sugita T; Sawada A; Watanabe S; Latham LP; Horwitz LD; Wagner WW
    Nihon Kyobu Shikkan Gakkai Zasshi; 1981 Nov; 19(11):820-5. PubMed ID: 6803050
    [No Abstract]   [Full Text] [Related]  

  • 34. [Toxic effects of aqueous extract of crotalariae assamicae semen in rats and possible mechanism in association with liver damage].
    Cheng M; Tang J; Jiang LQ; Jia ZM; Hattori M
    Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1800-5. PubMed ID: 24010299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrrolizidine Alkaloids.
    Tamariz J; Burgueño-Tapia E; Vázquez MA; Delgado F
    Alkaloids Chem Biol; 2018; 80():1-314. PubMed ID: 30001795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmembrane anion transport and cytotoxicity of synthetic tambjamine analogs.
    Hernando E; Soto-Cerrato V; Cortés-Arroyo S; Pérez-Tomás R; Quesada R
    Org Biomol Chem; 2014 Mar; 12(11):1771-8. PubMed ID: 24500335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity and metabolism of pyrrolizidine alkaloids.
    Cheeke PR
    J Anim Sci; 1988 Sep; 66(9):2343-50. PubMed ID: 3049495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus.
    Styles J; Ashby J; Mattocks AR
    Carcinogenesis; 1980 Feb; 1(2):161-4. PubMed ID: 22282996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pyrrolizidine alkaloids on liver microsome mixed-function oxidase activity in rats.
    Shull LR; Buckmaster GW; Cheeke PR
    J Anim Sci; 1976 Nov; 43(5):1024-7. PubMed ID: 977506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.